Lung cancer

Patients with chronic obstructive pulmonary disease are at increased risk for both the development of primary lung cancer, as well as poor outcome after lung cancer diagnosis and treatment. Because of existing impairments in lung function, patients with COPD often do not meet traditional criteria for tolerance of definitive surgical lung cancer therapy. Emerging information with respect to the pathophysiology of COPD in lung resection demonstrates that postoperative decrements in lung capacity may be less than anticipated by traditional prediction tools. In patients with COPD, more inclusive consideration for surgical resection with curative intent might be appropriate as constrained surgical resections or nonsurgical therapeutic options provide inferior survival. Besides, optimizing perioperative COPD therapeutic care as indicated by clinical practice rules including smoking cessation can possibly minimize morbidity and enhance functional status in this often severely impaired patient population. Lung Conferences concentrates on the risk factor for development of lung cancer.

  • Small-Cell Lung Carcinoma
  • Prognosis of Lung Cancer
  • Genetic susceptibility
  • Chronic inflammation

Related Conference of Lung cancer

August 17-18, 2020

10th International Conference on COPD and Lungs

Prague, Czech Republic
October 19-20, 2020

International Congress and Expo on Pulmonology

Manila, Philippines
October 29-30, 2020

International Conference on Lung Diseases

Cape Town, South Africa
November 18-19, 2020

International Conference on Asthma and Allergy

Lisbon, Portugal
December 07-08, 2020

8th Annual Congress on Pulmonary and Critical Care

Tokyo, Japan

Lung cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in